Reduction of the severity of nephropathy in aging Fischer 344 rats treated with analogs of arylsulfonyluria.
D000092:Acetohexamide / Q000009:adverse effects; D000818:Animals; D002747:Chlorpropamide / Q000009:adverse effects; D005260:Female; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D010629:Phenformin / Q000009:adverse effects; D051381:Rats; D011916:Rats, Inbred F344; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D014042:Tolazamide / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014042:Tolazamide; D010629:Phenformin; D000092:Acetohexamide; D002747:Chlorpropamide